文献速递关节外科

布比卡因脂质体经关节周围注射在全膝关节置换术中的疗效:系统综述与Meta分析

The Efficacy of Liposomal Bupivacaine Using Periarticular Injection in Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Arthroplasty · 2016-12-23

本Meta分析纳入11项比较布比卡因脂质体经关节周围注射(PAI)与传统PAI方法的研究,评估全膝关节置换术(TKA)后的疼痛与功能恢复。汇总分析显示布比卡因脂质体在24、48、72小时视觉模拟评分、阿片类药物总消耗量、关节活动度、住院时长、术后恶心及行走距离方面与对照组均无显著差异。作者结论认为,考虑到疼痛控制成本,布比卡因脂质体不值得推荐作为PAI方法的长效替代镇痛剂。

要点

  • 布比卡因脂质体组与对照组在24、48、72小时VAS评分均无显著差异(P=.46、P=.43、P=.21)。
  • 阿片类药物总消耗量、关节活动度、住院时长、术后恶心及行走距离组间均无显著差异。
  • 作者认为考虑到成本,布比卡因脂质体不值得推荐作为PAI的长效替代镇痛剂。

核心结论

  • 与传统PAI方法相比,布比卡因脂质体在TKA术后疼痛控制和功能恢复方面表现相似。
  • 考虑到疼痛控制成本,布比卡因脂质体不值得被推荐作为PAI方法的长效替代镇痛剂。

研究设计与样本

  • 系统综述与Meta分析,全面检索Web of Science、PubMed、Embase和Cochrane Library。
  • 纳入随机对照试验、对照临床试验和队列研究,共11项比较布比卡因脂质体PAI与传统PAI方法的研究。
  • 采用PRISMA指南和Cochrane手册评估纳入研究结果质量。

主要发现

  • 布比卡因脂质体组与对照组24小时VAS评分无显著差异(P=.46)。
  • 布比卡因脂质体组与对照组48小时VAS评分无显著差异(P=.43)。
  • 布比卡因脂质体组与对照组72小时VAS评分无显著差异(P=.21)。
  • 阿片类药物总消耗量组间无显著差异(P=.25)。
  • 关节活动度(P=.28)、住院时长(P=.53)、术后恶心(P=.34)及行走距离(P=.07)组间均无显著差异。

关键数值与推荐

  • 纳入标准为比较布比卡因脂质体PAI与传统PAI方法的随机对照试验、对照临床试验和队列研究。
  • 采用PRISMA指南和Cochrane手册评估纳入研究质量。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total knee arthroplasty (TKA) is gradually emerging as the treatment of choice for end-stage osteoarthritis. In the past, the method of liposomal bupivacaine by periarticular injection (PAI) showed better effects on pain reduction and opioid consumption after surgery. However, some recent studies have reported that liposomal bupivacaine by PAI did not improve pain control and functional recovery in patients undergoing TKA. Therefore, this meta-analysis was conducted to determine whether liposomal bupivacaine provides better pain relief and functional recovery after TKA. METHODS: Web of Science, PubMed, Embase, and the Cochrane Library were comprehensively searched. Randomized controlled trials, controlled clinical trials, and cohort studies were included in our meta-analysis. Eleven studies that compared liposomal bupivacaine using the PAI technique with the conventional PAI method were included in our meta-analysis. The preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines and Cochrane Handbook were applied to assess the quality of the results published in all included studies to ensure that the results of our meta-analysis were reliable and veritable. RESULTS: Our pooled data analysis demonstrated that liposomal bupivacaine was as effective as the control group in terms of visual analog scale score at 24 hours (P = .46), 48 hours (P = .43), 72 hours (P = .21), total amount of opioid consumption (P = .25), range of motion (P = .28), length of hospital stay (P = .53), postoperative nausea (P = .34), and ambulation distance (P = .07). CONCLUSION: Compared with the conventional PAI method, liposomal bupivacaine shows similar pain control and functional recovery after TKA. Considering the cost for pain control, liposomal bupivacaine is not worthy of being recommended as a long-acting alternative analgesic agent using the PAI method.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Kuang MJ, Du Y, Ma JX, et al. The Efficacy of Liposomal Bupivacaine Using Periarticular Injection in Total Knee Arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplasty. 2016. PMID: 28082044. doi:10.1016/j.arth.2016.12.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。